Home World News Sevabertinib Shows Antitumour Activity in Patients with Locally Advanced or Metastatic HER2-mutated... World News Sevabertinib Shows Antitumour Activity in Patients with Locally Advanced or Metastatic HER2-mutated NSCLC By Ogkologos - November 14, 2025 330 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SOHO-01 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Emma Stone Motivated to Help Others After Her Mother Was Diagnosed... November 16, 2020 Trastuzumab Deruxtecan Demonstrates Efficacy in HER2-positive and HER2-low Advanced Gastric Cancer July 6, 2021 Workout Wednesday – Back Stretches Part 2 July 29, 2020 Evidence for the Utility of ctDNA Monitoring for Recurrence After CRC... October 3, 2024 Load more HOT NEWS Prostate cancer: Lessons Learned from My Breast Cancer Evaluating Targeted Therapy for People With Advanced Gastric or Gastroesophageal Junction... Can Targeted Therapy for KRAS Mutations Double as Part of Immunotherapy? Chemotherapy Administered for the First Diagnosed Testicular Cancer Reduces the Risk...
